Ampa Receptor Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
AMPA Receptor (α-amino5-methyl-4-3-hydroxy--isoxazolepropionic acid receptor) is an ionotropic glutamate receptor that mediates the majority of fast excitatory synaptic transmission in the brain. It is critical for synaptic plasticity, learning, and memory. Dysfunction of AMPA receptors is implicated in Alzheimer's disease, Parkinson's disease, and various neurological disorders.
AMPA receptors are glutamate-gated cation channels that mediate rapid excitatory neurotransmission in the central nervous system. They are composed of four subunits (GluA1-4) that assemble to form tetramers. The receptor's properties are determined by subunit composition, making it a key target for therapeutic intervention in neurodegenerative diseases.
AMPA receptors are ligand-gated ion channels:
- GluA1 (906 aa): Major subunit, trafficking regulated
- GluA2 (862 aa): RNA-edited, controls Ca2+ permeability
- GluA3 (894 aa): Synaptic plasticity role
- GluA4 (881 aa): Expression in specific brain regions
- Four subunits per receptor
- Ligand-binding domain (LBD)
- Transmembrane domain (TMD)
- Intracellular C-terminal tail
- Molecular weight: ~100 kDa per subunit
- GluA2 Q/R site: ADAR-mediated editing
- Controls Ca2+ permeability
- Essential for normal function
AMPA receptors are expressed throughout the brain:
- Fast Excitatory Transmission: Primary mediators
- Synaptic Plasticity: LTP and LTD
- Learning and Memory: Essential for cognition
- Neuronal Development: Activity-dependent pruning
- Circuit Formation: Refines neural circuits
- Homeostatic Scaling: Synaptic strength regulation
- Kinase regulation: PKA, PKC, CaMKII
- Protein interactions: GRIP, PICK1, NSF
- Trafficking: Activity-dependent insertion
AMPA receptors in AD:
- Synaptic Loss: Early target of Aβ
- Dysfunction: Impaired LTP
- Trafficking: Reduced surface expression
- Tau: Affects receptor localization
- Altered expression in PD models
- Role in dopaminergic signaling
- Therapeutic target potential
- Stroke: Excitotoxicity
- Epilepsy: Seizure susceptibility
- ALS: Motor neuron dysfunction
- Depression: AMPA potentiators
AMPA in plasticity:
- Ca2+ influx through receptors
- CaMKII activation
- Phosphorylation of receptors
- Receptor trafficking changes
Pathological activation:
- Excessive glutamate release
- Overactivation of AMPA receptors
- Excessive Ca2+ influx
- Cell death pathways
| Strategy |
Status |
Notes |
| AMPA modulators |
Approved |
Perampanel for seizures |
| AMPA potentiators |
Research |
Enhance cognition |
| Antagonists |
Clinical |
Stroke, excitotoxicity |
| Subunit-selective |
Discovery |
Targeted approaches |
- Perampanel: Approved for seizures
- Ampakines: Cognitive enhancement
- CX-516: Tested in AD/PD
- Subunit-selective compounds
- Allosteric modulators
- Trafficking modulators
- Disease-specific approaches
- Knockout mice
- Transgenic models
- iPSC neurons
- Huganir et al. (2013) "AMPA receptors in synaptic plasticity" Neuron[1]
- Henley et al. (2011) "AMPA receptor trafficking" Annu Rev Biochem[2]
- Twomey et al. (2017) "AMPA receptor structure" Nat Rev Neurosci[3]
- Liu et al. (2018) "AMPA in neurodegeneration" Brain[4]
The study of Ampa Receptor Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] AMPA receptor regulation. PMID:24217888
[2] AMPA receptor trafficking. PMID:21382550
[3] AMPA receptor structure. PMID:29237747
[4] AMPA in neurodegeneration. PMID:29848462